SCHEMBL2633100

SCHEMBL2633100

FC(F)(F)c1ccc(-c2cc(-c3ccc(C(F)(F)F)cc3)cc(-c3cc4c5ccccc5c5c6ccccc6n(-c6ccccc6)c5c4c4ccccc34)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 2/20 0.39
▸ PPARG P37231 3/20 0.37
▸ PPARA Q07869 2/20 0.37
▸ KDM4E B2RXH2 3/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ GLO1 Q04760 1/20 0.35
▸ MGAM O43451 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ SI P14410 1/20 0.35
▸ MGAM2 Q2M2H8 1/20 0.35
▸ MAT2A P31153 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TDP2 O95551 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2627518 0.95 ALDH1A1 (0.36) KIF11PPARGPPARAKDM4EATM
SCHEMBL2627503 0.82 MAPT (0.38) KDM4EATML3MBTL1GAAMEN1
SCHEMBL2627517 0.82 L3MBTL1 (0.38) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL10063544 0.81 KIF11 (0.36) KIF11PPARGPPARAGLO1MGAM
SCHEMBL23741538 0.80 L3MBTL1 (0.41) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL2627502 0.78 KDM4E (0.41) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL2627514 0.77 L3MBTL1 (0.38) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL2627550 0.77 PIK3CA (0.37) KIF11MGAMGAASIMGAM2
SCHEMBL17245551 0.77 L3MBTL1 (0.48) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL23741279 0.77 L3MBTL1 (0.37) KDM4EATML3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9362506-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-07 — — US disclosed
US-20140291654-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2014-10-02 — — US disclosed
US-8815417-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2014-08-26 — — US disclosed
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120097929-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY2, CRY1, CCNE2 KIF11 3044/4885PPARG 1053/4885PPARA 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback